Ataxin 1 Rabbit Monoclonal Antibody, Unconjugated

Artikelnummer: EKL-AMRE86494
Artikelname: Ataxin 1 Rabbit Monoclonal Antibody, Unconjugated
Artikelnummer: EKL-AMRE86494
Hersteller Artikelnummer: AMRe86494
Alternativnummer: EKL-AMRE86494-50UL,EKL-AMRE86494-100UL
Hersteller: EnkiLife
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IP, WB
Spezies Reaktivität: Human
Konjugation: Unconjugated
Alternative Synonym: ATX1, SCA1, D6S504E
The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the pure cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 40-83 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). At least two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2016]
Klonalität: Monoclonal
Molekulargewicht: Calculated MW:87 kDa, Observed MW:105 kDa
NCBI: 6310
UniProt: P54253
Puffer: Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.
Reinheit: Affinity Purification
Formulierung: Liquid
Target-Kategorie: Ataxin 1
Application Verdünnung: WB 1:1000-1:5000,IP 1:20-1:50